-+ 0.00%
-+ 0.00%
-+ 0.00%

*LSL Pharma Consideration for Transaction Includes Renewal of Dermolab's Operating Line of Credit and Term Loan Totaling Maximum of C$3M, Cash Payment of C$955,000

Dow Jones·12/18/2024 13:03:00

Please log in to view news